High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells

IF 5.1 Q1 ONCOLOGY Lung Cancer: Targets and Therapy Pub Date : 2016-05-02 DOI:10.2147/LCTT.S90694
H. Tian, Xing Li, Wenli Jiang, Cuiting Lv, Weizhang Sun, Caiguo Huang, Ruohua Chen
{"title":"High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells","authors":"H. Tian, Xing Li, Wenli Jiang, Cuiting Lv, Weizhang Sun, Caiguo Huang, Ruohua Chen","doi":"10.2147/LCTT.S90694","DOIUrl":null,"url":null,"abstract":"AKR1C1 is a member of the AKR1C family, which not only plays an important role in hormone metabolism but is believed to be involved in carcinogen metabolism. Our previous study demonstrated that AKR1C1 was highly expressed in lung tumor tissues as compared with the tumor-adjacent tissues. Small-cell lung cancer (SCLC) is a special type of lung cancer. Surgical treatment of SCLC is usually difficult due to the high degree of malignancy and early metastasis, and difficulty in obtaining clinical specimens. There is not much basic or clinical research on SCLC in the People’s Republic of China even in recent years. To investigate the mechanism of AKR1C1 in the pathogenesis of SCLC, the present study used H446 cell line to see whether AKR1C1 could affect the proliferation or migration of SCLC cells, and used a lentivirus to build the AKR1C1 overexpression and under-expression cell lines. The results indicated that AKR1C1 was an important inducement in the proliferation and migration of H446 cells. AKR1C1 promoted cell proliferation and played a vital role in the migration of SCLC cells. These results were also verified in nude mice in vivo. In conclusion, AKR1C1 plays an important role in the development and progression of SCLC and may represent an independent biomarker for assessment of the primary prognosis and therapy of SCLC.","PeriodicalId":18066,"journal":{"name":"Lung Cancer: Targets and Therapy","volume":"26 1","pages":"53 - 61"},"PeriodicalIF":5.1000,"publicationDate":"2016-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"29","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer: Targets and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/LCTT.S90694","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 29

Abstract

AKR1C1 is a member of the AKR1C family, which not only plays an important role in hormone metabolism but is believed to be involved in carcinogen metabolism. Our previous study demonstrated that AKR1C1 was highly expressed in lung tumor tissues as compared with the tumor-adjacent tissues. Small-cell lung cancer (SCLC) is a special type of lung cancer. Surgical treatment of SCLC is usually difficult due to the high degree of malignancy and early metastasis, and difficulty in obtaining clinical specimens. There is not much basic or clinical research on SCLC in the People’s Republic of China even in recent years. To investigate the mechanism of AKR1C1 in the pathogenesis of SCLC, the present study used H446 cell line to see whether AKR1C1 could affect the proliferation or migration of SCLC cells, and used a lentivirus to build the AKR1C1 overexpression and under-expression cell lines. The results indicated that AKR1C1 was an important inducement in the proliferation and migration of H446 cells. AKR1C1 promoted cell proliferation and played a vital role in the migration of SCLC cells. These results were also verified in nude mice in vivo. In conclusion, AKR1C1 plays an important role in the development and progression of SCLC and may represent an independent biomarker for assessment of the primary prognosis and therapy of SCLC.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
AKR1C1的高表达与小细胞肺癌细胞的增殖和迁移有关
AKR1C1是AKR1C家族的一员,不仅在激素代谢中起重要作用,而且被认为与致癌物质代谢有关。我们前期的研究表明,与肿瘤邻近组织相比,AKR1C1在肺肿瘤组织中高表达。小细胞肺癌(SCLC)是一种特殊类型的肺癌。由于SCLC的恶性程度高、早期转移,且临床标本难以获取,手术治疗往往比较困难。近年来,中国对SCLC的基础和临床研究也不多。为了探讨AKR1C1在SCLC发病中的作用机制,本研究利用H446细胞系观察AKR1C1是否会影响SCLC细胞的增殖或迁移,并利用慢病毒构建AKR1C1过表达和过表达细胞系。结果表明,AKR1C1对H446细胞的增殖和迁移具有重要的诱导作用。AKR1C1促进细胞增殖,并在SCLC细胞的迁移中发挥重要作用。这些结果也在裸鼠体内得到了验证。综上所述,AKR1C1在SCLC的发生和进展中发挥着重要作用,可能是评估SCLC原发性预后和治疗的独立生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.10
自引率
0.00%
发文量
10
审稿时长
16 weeks
期刊最新文献
Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea. Adagrasib in KRYSTAL-12 has Broken the KRAS G12C Enigma Code in Non-Small Cell Lung Carcinoma. NRG1 Fusions in NSCLC: Being eNRGy Conscious. Pulmonary Spindle Cell Carcinoma Mimicking Granulomatous Inflammation: A Rare Case Report and Brief Review of the Literature. Redefining Recovery: The Transformative Impact of the ALINA Trial on Adjuvant Therapy for ALK-Positive Non-Small Cell Lung Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1